RAMM Pharma Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020
Cash & Equivalents	0.53	0.81	5.12	9.77	17.16	28.01
Cash & Short-Term Investments	0.53	0.81	5.12	9.77	17.16	28.01
Cash Growth	-64.91%	-84.09%	-47.65%	-43.03%	-38.74%	-20.82%
Accounts Receivable	0.84	0.78	0.62	0.92	1.17	1.1
Other Receivables	0.72	0.86	1.26	1.83	2.78	0.25
Receivables	1.56	1.64	1.88	2.74	3.95	1.35
Inventory	1.59	2.54	3.14	4.02	3.05	1.79
Prepaid Expenses	0.02	0.26	0.22	0.08	0.06	-
Other Current Assets	0.07	0.1	0.24	0.03	0.06	0.07
Total Current Assets	3.76	5.36	10.59	16.65	24.28	31.22
Property, Plant & Equipment	11.17	11.2	19.05	19.71	19.34	2.29
Goodwill	-	-	-	-	12.85	-
Other Intangible Assets	0	0.19	0.49	0.8	1.47	1.46
Other Long-Term Assets	-	-	2.17	2.08	1.86	2.2
Total Assets	14.94	16.75	32.3	39.24	59.8	37.17
Accounts Payable	0.49	0.64	1.21	1.11	1.93	0.5
Accrued Expenses	0.2	0.36	0.33	0.56	0.48	0.45
Current Portion of Leases	0.03	0.1	0.23	0.23	0.03	0.08
Current Income Taxes Payable	-	0.01	0.01	0.01	0	0
Other Current Liabilities	1.81	1.92	0.87	1.3	0.87	0.28
Total Current Liabilities	2.53	3.03	2.66	3.2	3.32	1.32
Long-Term Leases	-	0.08	0.18	0.45	0	0.02
Long-Term Deferred Tax Liabilities	-	-	-	-	0.09	-
Total Liabilities	2.53	3.11	2.84	3.66	3.41	1.34
Common Stock	60.99	60.99	60.99	62.52	63.06	41.37
Additional Paid-In Capital	6.96	6.87	3.05	1.36	1.36	-
Retained Earnings	-67.66	-65.91	-49.45	-43.09	-22.44	-15.35
Comprehensive Income & Other	12.12	11.69	14.88	14.79	14.42	9.82
Shareholders' Equity	12.41	13.63	29.46	35.59	56.39	35.84
Total Liabilities & Equity	14.94	16.75	32.3	39.24	59.8	37.17
Total Debt	0.03	0.19	0.41	0.68	0.03	0.1
Net Cash (Debt)	0.5	0.63	4.71	9.09	17.12	27.91
Net Cash Growth	-60.22%	-86.72%	-48.16%	-46.92%	-38.64%	-15.65%
Net Cash Per Share	0.00	0.01	0.04	0.07	0.16	0.28
Filing Date Shares Outstanding	119.39	119.39	119.39	122.4	123.45	99.46
Total Common Shares Outstanding	119.39	119.39	119.39	122.4	123.45	99.72
Working Capital	1.23	2.33	7.93	13.45	20.97	29.9
Book Value Per Share	0.10	0.11	0.25	0.29	0.46	0.36
Tangible Book Value	12.4	13.45	28.97	34.78	42.07	34.37
Tangible Book Value Per Share	0.10	0.11	0.24	0.28	0.34	0.34
Land	3.44	3.7	4.58	4.42	4.18	2.22
Machinery	5.49	5.66	6.06	5.82	4.76	1.81
Construction In Progress	6.92	6.32	12.05	11.96	12.66	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.